Remifentanil Requirement for Acceptable Intubating Condition
NCT ID: NCT02655380
Last Updated: 2019-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
51 participants
INTERVENTIONAL
2017-06-19
2018-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade
NCT02454868
Remifentanil and Atropine for Intubation in Neonates
NCT00815048
Effect of Ketamine+Propofol vs Remifentanyl+Propofol on Laryngeal Mask Insertion Conditions
NCT02583217
The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study
NCT07089173
Co-induction Ketamine-propofol: Effects on Laryngeal Mask Airway Insertion Conditions in Children
NCT03631875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ketamine 1
Anesthesia induction with ketamine 1 mg followed by remifentanil.
Ketamine 1
Anesthesia induction is performed with 1 mg ketamine.
Remifentanil
After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.
ketamine 2
Anesthesia induction with ketamine 2 mg followed by remifentanil.
Ketamine 2
Anesthesia induction is performed with 2 mg ketamine.
Remifentanil
After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketamine 1
Anesthesia induction is performed with 1 mg ketamine.
Ketamine 2
Anesthesia induction is performed with 2 mg ketamine.
Remifentanil
After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing general anesthesia with endotracheal tube
Exclusion Criteria
* Patient with upper respiratory infection within 14 days
* Asthma
3 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajou University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
yun jeong chae
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
yun jeong chae, Ph.D
Role: STUDY_DIRECTOR
Ajou University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou universitiy school of medicine
Suwon, Gyeong-gi Do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MED-DRU-15-354
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.